
eureKARE is a visionary investment firm dedicated to advancing synthetic biology innovation throughout Europe. With a firm belief in the transformative potential of synthetic biology to address global health and environmental challenges, eureKARE's seasoned team is committed to leveraging Europe's burgeoning expertise in this field. By pioneering a novel startup creation and development model, eureKARE fosters a vibrant ecosystem of early and later-stage ventures through its network of biotech studios. These studios serve as pivotal bridges between academia and industry, accelerating innovations into robust companies equipped to thrive and deliver societal benefits.